Organovo Logo     Print Page | Close Window

Investor Overview

Who is Organovo?
  • We participate in attractive and growing markets with critical unmet needs
  • We benefit from favorable competitive dynamics and a first mover advantage
  • We’re a technology leader with a strong IP portfolio
  • We’re leveraging our technology platform to build a robust product and service platform across the high-value drug profiling and therapeutic tissues markets
2017 Annual Report Investor Presentation

Stock Information
ONVO (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) - 0.03 (1.72%)
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: ONVO.O.  Currently trading at $1.71 with a 52 week high of $3.19 and a 52 week low of $0.91.
Recent Investor News
Organovo Announces Release Date for Fiscal Fourth-Quarter 2018 Financial Results
Organovo to Present New Preclinical Data for Its Liver Therapeutic Tissue IND-Track Programs at the World Advanced Therapies and Regenerative Medicine Congress
Investor Events
Thursday, May 31, 2018 5:00 p.m. ET
Organovo Holdings, Inc. Fourth Quarter Earnings Conference Call
Featured Reports
2017 Annual Report
2017 Proxy Statement
Latest Tweets